Search results for " Complete"

showing 7 items of 97 documents

Formaciones sociales y opresión en Marx

2018

The text explains the difference between Marx?s concept of «oppression» and others as «coercion» by Durkheim or «domination» by Weber. The article then establishes, in a methodical way, the centrality of a passage from Capital, in which three different theories on «oppression» appear. It?s explained that two of them are rather a philosophical antinomy. The other, relative to the heteronomy of social time, can be completed by defining the heteronomy of social space, which gives it analytical virtuality. Some examples are given.

in a methodical wayvalorrelative to the heteronomy of social timetiempo de trabajoworking timethe centrality of a passage from Capitalcan be completed by defining the heteronomy of social space:SOCIOLOGÍA [UNESCO]in which three different theories on «oppression» appear. It?s explained that two of them are rather a philosophical antinomy. The othervalueespacio socialopresiónMarxUNESCO::SOCIOLOGÍA1137-7038 8537 Arxius de sociologia 493757 2018 38 6508342 Formaciones sociales y opresión en Marx Hernàndez i DobonFrancesc Jesús The text explains the difference between Marx?s concept of «oppression» and others as «coercion» by Durkheim or «domination» by Weber. The article then establishessocial space. 27 35oppressionwhich gives it analytical virtuality. Some examples are given. Marx
researchProduct

Apoptotic-like Leishmania exploit the host´s autophagy machinery to reduce T-cell-mediated parasite elimination

2015

Apoptosis is a well-defined cellular process in which a cell dies, characterized by cell shrinkage and DNA fragmentation. In parasites like Leishmania, the process of apoptosis-like cell death has been described. Moreover upon infection, the apoptotic-like population is essential for disease development, in part by silencing host phagocytes. Nevertheless, the exact mechanism of how apoptosis in unicellular organisms may support infectivity remains unclear. Therefore we investigated the fate of apoptotic-like Leishmania parasites in human host macrophages. Our data showed--in contrast to viable parasites--that apoptotic-like parasites enter an LC3(+), autophagy-like compartment. The compartm…

log.ph logarithmic phaseT-LymphocytesApoptosisMACS magnetic-associated cell sortingMacrophageMFI mean fluorescence intensityLeishmaniasisMOI multiplicity of infectionanti-inflammatoryLeishmaniaeducation.field_of_studyPhagocytesCFSE carboxyfluorescein succinimidyl esterTGFB transforming growth factorAcquired immune systemapoptotic-like LeishmaniaPS phosphatidylserinehuman primary macrophagesCell biologyβ; TT tetanus toxoidCorrigendumProgrammed cell deathautophagyPopulationAntigen presentationANXA5 annexin VBasic Science Research PapersBiologyPhagocytosisCM complete mediumMAP1LC3/LC3 microtubule-associated protein 1 light chain 3AnimalsHumansMHC major histocompatibility complexIF immunofluorescenceeducationMolecular Biologyimmune evasionPBMCs peripheral blood mononuclear cellsT-cell proliferationIntracellular parasiteMacrophagesstat.ph stationary phaseAutophagyLm LeishmaniaCell BiologyLeishmaniabiology.organism_classificationIL interleukinLAP LC3-associated phagocytosisLAPhMDM human monocyte derived macrophageAutophagy
researchProduct

Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective …

2018

Abstract Background: Triplet-based lenalidomide plus dexamethasone (Rd) combinations have become the new standard of care for early relapse and refractory multiple myeloma (RRMM). Carfilzomib is a novel selective proteasome inhibitor (PI) with high efficacy in RRMM. The ASPIRE phase 3 trial showed the superiority of carfilzomib-based triplet (KRd compared to Rd), leading to approval of K for RRMM. However, little is known about safety and efficacy of KRd outside a clinical trial context. Experimental design and aims: In 11 Sicilian Centers belonging to the Sicilian Myeloma Network, from November 2016, when KRd regimen was approved in Italy, to June 2018, 103 consecutive RRMM patients (previ…

medicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiescomplete remissionImmunologylenalidomideadverse eventContext (language use)dexamethasoneBiochemistrychemistry.chemical_compoundMedian follow-upInternal medicinemedicinecarfilzomib dexamethasone lenalidomide multiple myeloma toxic effect adverse event bortezomib complete remission erythropoietin febrile neutropeniaMultiple myelomaLenalidomidetoxic effectcarfilzomibbusiness.industryCumulative dosebortezomibCell BiologyHematologymedicine.diseaseCarfilzomibmultiple myelomaRegimenfebrile neutropeniachemistryerythropoietinbusinessFebrile neutropeniamedicine.drug
researchProduct

Modal Consequence Relations Extending S4.3: An Application of Projective Unification

2016

We characterize all finitary consequence relations over $\mathbf{S4.3}$ , both syntactically, by exhibiting so-called (admissible) passive rules that extend the given logic, and semantically, by providing suitable strongly adequate classes of algebras. This is achieved by applying an earlier result stating that a modal logic $L$ extending $\mathbf{S4}$ has projective unification if and only if $L$ contains $\mathbf{S4.3}$ . In particular, we show that these consequence relations enjoy the strong finite model property, and are finitely based. In this way, we extend the known results by Bull and Fine, from logics, to consequence relations. We also show that the lattice of consequence relation…

projective unificationPure mathematicsUnificationLogicFinite model property02 engineering and technology68T15Lattice (discrete subgroup)01 natural sciencesadmissible rulesComputer Science::Logic in Computer Science0202 electrical engineering electronic engineering information engineeringCountable setFinitaryHeyting algebra08C150101 mathematics03B45MathematicsDiscrete mathematics010102 general mathematicsquasivarietiesModal logicstructural completenessconsequence relations03B35Distributive property06E25$\mathbf{S4.3}$S4.3020201 artificial intelligence & image processingNotre Dame Journal of Formal Logic
researchProduct

Predictive models in assessment of macroinvertebrates in boreal rivers

2009

Jukka Aroviita tutki väitöskirjassaan jokien ja purojen biologisen tilan mittaamismenetelmiä. Aroviita osoitti, että ihmistoiminnan aiheuttamat biologiset muutokset voivat jäädä havaitsematta, jos eliöyhteisöjen luonnollista taustavaihtelua ei oteta kunnolla huomioon.- Tällöin vesistöjen saatetaan arvioida olevan paremmassa kunnossa kuin ne todellisuudessa ovatkaan. Muutosten tunnistamistarkkuuden tulisi olla mahdollisimman hyvä, sillä tila-arvioilla on myös juridisesti määräytyviä yhteiskunnallisia ja taloudellisia seuraamuksia, Aroviita toteaa. Vielä 1990-luvulla järvien ja jokien tilaa arvioitiin suurelta osin ihmisen näkökulmasta ja veden kemian perusteella. Nykylainsäädäntö edellyttää …

spatial scalebioassessmentpohjaeläimistöRIVPACSbiotic qualitytaxonomic completenessvirtavedetvertailuololähestymistapaennustavat mallitmacroinvertebratestypologystreamstypologiat
researchProduct

Sensitivity of bipartite network analyses to incomplete sampling and taxonomic uncertainty

2023

Bipartite network analysis is a powerful tool to study the processes structuring interactions in ecological communities. In applying the method, it is assumed that the sampled interactions provide an accurate representation of the actual community. However, acquiring a representative sample may be difficult as not all species are equally abundant or easily identifiable. Two potential sampling issues can compromise the conclusions of bipartite network analyses: failure to capture the full range of interactions (sampling completeness) and use of a taxonomic level higher than species to evaluate the network (taxonomic resolution). We asked how commonly used descriptors of bipartite antagonisti…

taxonomic resolutionverkkoteoriasystematiikka (biologia)eliöyhteisötsampling completenessisäntälajitbipartite networkssampling issueshost-parasite interactionsbipartite networks; host–parasite interactions; sampling completeness; sampling issues; taxonomic resolutionloisethost–parasite interactionsotantanäytteenottoEcology Evolution Behavior and Systematics
researchProduct

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

2021

Background & aims Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety of OCA under real-world conditions. Methods Patients were recruited into the Italian PBC Registry, a multicentre, observational cohort study that monitors patients with PBC at national level. The primary endpoint was the biochemical response according to Poise criteria; the secondary endpoint was the biochemical response according to normal range criteria, defined as normal levels of bilirubin, alkaline phosphatase (ALP), and alanine aminotransfer…

upper limit of normalCirrhosisALTAMAAutoimmunityantinuclear antibodiesULNPBCGastroenterologyUDCASettore MED/12ULN upper limit of normalobeticholic acidaRR adjusted risk ratio.CRFs case record formAST aspartate transferaseClinical endpointGGT gamma-glutamyl transferaseQCprimary biliary cholangitisGastroenterologyUrsodeoxycholic acidANATCCCirrhosisCholestasiTIPSTreatment Completer CohortANA antinuclear antibodiemedicine.medical_specialtyRRUDCA ursodeoxycholic acidTIPS transjugular intrahepatic portosystemic shuntOCACirrhosiALP alkaline phosphataseautoimmune hepatitismedicine.diseasedigestive system diseasesDiscontinuationKeywords: AIH autoimmune hepatitiQC quality controlchemistrygamma-glutamyl transferaserandomised controlled trialelectronic data captureantimitochondrial antibodiesaspartate transferaseAutoimmune hepatitischemistry.chemical_compoundAIHCRFsImmunology and Allergyadjusted risk ratioANA antinuclear antibodiesRR risk ratioOverall cohortALT alanine transferaseAMA antimitochondrial antibodieCholestasisCRFs case record formsObeticholic acidOverlap PBC-AIHursodeoxycholic acidOCA obeticholic acidTolerabilityalkaline phosphataseRCTResearch Articlemedicine.drugcase record formsContext (language use)AMA antimitochondrial antibodiesInternal medicineEDC electronic data capturetransjugular intrahepatic portosystemic shuntInternal MedicinemedicineRCT randomised controlled trialaRR adjusted risk ratioOClcsh:RC799-869quality controlalanine transferaseASTaRRHepatologybusiness.industryAutoimmunity; Cholestasis; Cirrhosis; Overlap PBC-AIHAIH autoimmune hepatitisTCC Treatment Completer CohortPBC primary biliary cholangitiGGTrisk ratioOC Overall cohortALPlcsh:Diseases of the digestive system. GastroenterologyPBC primary biliary cholangitisbusinessEDC
researchProduct